Skip to content
healthcare.dev

E-Z-GAS II

NDC 10361-793, Antacid/AntiFlatulent, granule, effervescent, from E-Z-EM, INC..

Product NDC
10361-793
Status
Listed
Labeler
E-Z-EM, INC.
Dosage form
GRANULE, EFFERVESCENT
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10361-793 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANHYDROUS CITRIC ACID380 mg/g
  • SODIUM BICARBONATE550 mg/g
  • DIMETHICONE10 mg/g
  • SILICON DIOXIDE10 mg/g

Pharmacologic classes

Acidifying Activity [MoA]; Alkalinizing Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]; Skin Barrier Activity [PE]

Package NDCNDC-11Package
10361-793-011036107930150 POUCH in 1 BOX (10361-793-01) / 4 g in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 10361-793 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10361-793 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10361-793. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.